The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma

Eun Ran Park, Sang Bum Kim, Jee San Lee, Yang Hyun Kim, Dong Hyoung Lee, Eung Ho Cho, Sun Hoo Park, Chul Ju Han, Bu Yeo Kim, Dong Wook Choi, Young Do Yoo, Ami Yu, Jae Won Lee, Ja June Jang, Young Nyun Park, Kyung Suk Suh, Kee Ho Lee

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Alterations in mitochondrial respiration contribute to the development and progression of cancer via abnormal biogenesis, including generation of reactive oxygen species. Ubiquinol–cytochrome c reductase hinge protein (UQCRH) consists of the cytochrome bc1 complex serving respiration in mitochondria. In the present study, we analyzed UQCRH abnormalities in hepatocellular carcinoma (HCC) and its association with clinical outcomes of patients. UQCRH expression in HCC was determined via semiquantitative and quantitative real-time reverse transcriptase polymerase chain reaction of 96 surgically resected HCC tissues positive for hepatitis B virus surface antigen. UQCRH was frequently overexpressed in HCC tissues (46.8%, based on 2.1-fold cutoff). UQCRH overexpression was observed in HCCs with larger tumor size, poorer differentiation, or vascular invasion. Kaplan–Meier analysis revealed significantly shorter overall (P = 0.005) and recurrence-free survival (P = 0.027) in patients with tumors overexpressing UQCRH. The prognostic impact of UQCRH was significant in subgroups of patients divided according to the α-fetoprotein (AFP) level. The patient subgroup with higher AFP levels (≥20 ng/mL) exhibited significant differences in 5-year overall (18.5% vs. 67.9%) and recurrence-free survival rates (11.1% vs. 46.4%) between groups with and without UQCRH overexpression. In contrast, no marked survival differences were observed between subgroups with lower AFP levels (<20 ng/mL). Multivariate analysis defined UQCRH as an independent poor prognostic factor. Conclusively, our results indicate that UQCRH overexpression is correlated with poor outcomes of HCC patients. Furthermore, in patients grouped as high risk based on elevated AFP, lack of UQCRH overexpression could be a useful indicator for clinical treatment.

Original languageEnglish
Pages (from-to)749-760
Number of pages12
JournalCancer Medicine
Volume6
Issue number4
DOIs
Publication statusPublished - 2017 Apr 1

Fingerprint

Mitochondrial Proteins
Hepatocellular Carcinoma
Oxidoreductases
Fetal Proteins
Proteins
Respiration
Recurrence
Neoplasms
Survival
Electron Transport Complex III
Hepatitis B Surface Antigens
Reverse Transcriptase Polymerase Chain Reaction
Hepatitis B virus
Blood Vessels
Real-Time Polymerase Chain Reaction
Reactive Oxygen Species
Mitochondria
Multivariate Analysis
Survival Rate

Keywords

  • AFP
  • hepatocellular carcinoma
  • Mitochondria
  • Prognosis
  • UQCRH overexpression

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Park, E. R., Kim, S. B., Lee, J. S., Kim, Y. H., Lee, D. H., Cho, E. H., ... Lee, K. H. (2017). The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma. Cancer Medicine, 6(4), 749-760. https://doi.org/10.1002/cam4.1042

The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma. / Park, Eun Ran; Kim, Sang Bum; Lee, Jee San; Kim, Yang Hyun; Lee, Dong Hyoung; Cho, Eung Ho; Park, Sun Hoo; Han, Chul Ju; Kim, Bu Yeo; Choi, Dong Wook; Yoo, Young Do; Yu, Ami; Lee, Jae Won; Jang, Ja June; Park, Young Nyun; Suh, Kyung Suk; Lee, Kee Ho.

In: Cancer Medicine, Vol. 6, No. 4, 01.04.2017, p. 749-760.

Research output: Contribution to journalArticle

Park, ER, Kim, SB, Lee, JS, Kim, YH, Lee, DH, Cho, EH, Park, SH, Han, CJ, Kim, BY, Choi, DW, Yoo, YD, Yu, A, Lee, JW, Jang, JJ, Park, YN, Suh, KS & Lee, KH 2017, 'The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma', Cancer Medicine, vol. 6, no. 4, pp. 749-760. https://doi.org/10.1002/cam4.1042
Park, Eun Ran ; Kim, Sang Bum ; Lee, Jee San ; Kim, Yang Hyun ; Lee, Dong Hyoung ; Cho, Eung Ho ; Park, Sun Hoo ; Han, Chul Ju ; Kim, Bu Yeo ; Choi, Dong Wook ; Yoo, Young Do ; Yu, Ami ; Lee, Jae Won ; Jang, Ja June ; Park, Young Nyun ; Suh, Kyung Suk ; Lee, Kee Ho. / The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma. In: Cancer Medicine. 2017 ; Vol. 6, No. 4. pp. 749-760.
@article{79e9dd9c46ea4e2893e2b09c9ef89511,
title = "The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma",
abstract = "Alterations in mitochondrial respiration contribute to the development and progression of cancer via abnormal biogenesis, including generation of reactive oxygen species. Ubiquinol–cytochrome c reductase hinge protein (UQCRH) consists of the cytochrome bc1 complex serving respiration in mitochondria. In the present study, we analyzed UQCRH abnormalities in hepatocellular carcinoma (HCC) and its association with clinical outcomes of patients. UQCRH expression in HCC was determined via semiquantitative and quantitative real-time reverse transcriptase polymerase chain reaction of 96 surgically resected HCC tissues positive for hepatitis B virus surface antigen. UQCRH was frequently overexpressed in HCC tissues (46.8{\%}, based on 2.1-fold cutoff). UQCRH overexpression was observed in HCCs with larger tumor size, poorer differentiation, or vascular invasion. Kaplan–Meier analysis revealed significantly shorter overall (P = 0.005) and recurrence-free survival (P = 0.027) in patients with tumors overexpressing UQCRH. The prognostic impact of UQCRH was significant in subgroups of patients divided according to the α-fetoprotein (AFP) level. The patient subgroup with higher AFP levels (≥20 ng/mL) exhibited significant differences in 5-year overall (18.5{\%} vs. 67.9{\%}) and recurrence-free survival rates (11.1{\%} vs. 46.4{\%}) between groups with and without UQCRH overexpression. In contrast, no marked survival differences were observed between subgroups with lower AFP levels (<20 ng/mL). Multivariate analysis defined UQCRH as an independent poor prognostic factor. Conclusively, our results indicate that UQCRH overexpression is correlated with poor outcomes of HCC patients. Furthermore, in patients grouped as high risk based on elevated AFP, lack of UQCRH overexpression could be a useful indicator for clinical treatment.",
keywords = "AFP, hepatocellular carcinoma, Mitochondria, Prognosis, UQCRH overexpression",
author = "Park, {Eun Ran} and Kim, {Sang Bum} and Lee, {Jee San} and Kim, {Yang Hyun} and Lee, {Dong Hyoung} and Cho, {Eung Ho} and Park, {Sun Hoo} and Han, {Chul Ju} and Kim, {Bu Yeo} and Choi, {Dong Wook} and Yoo, {Young Do} and Ami Yu and Lee, {Jae Won} and Jang, {Ja June} and Park, {Young Nyun} and Suh, {Kyung Suk} and Lee, {Kee Ho}",
year = "2017",
month = "4",
day = "1",
doi = "10.1002/cam4.1042",
language = "English",
volume = "6",
pages = "749--760",
journal = "Cancer Medicine",
issn = "2045-7634",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma

AU - Park, Eun Ran

AU - Kim, Sang Bum

AU - Lee, Jee San

AU - Kim, Yang Hyun

AU - Lee, Dong Hyoung

AU - Cho, Eung Ho

AU - Park, Sun Hoo

AU - Han, Chul Ju

AU - Kim, Bu Yeo

AU - Choi, Dong Wook

AU - Yoo, Young Do

AU - Yu, Ami

AU - Lee, Jae Won

AU - Jang, Ja June

AU - Park, Young Nyun

AU - Suh, Kyung Suk

AU - Lee, Kee Ho

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Alterations in mitochondrial respiration contribute to the development and progression of cancer via abnormal biogenesis, including generation of reactive oxygen species. Ubiquinol–cytochrome c reductase hinge protein (UQCRH) consists of the cytochrome bc1 complex serving respiration in mitochondria. In the present study, we analyzed UQCRH abnormalities in hepatocellular carcinoma (HCC) and its association with clinical outcomes of patients. UQCRH expression in HCC was determined via semiquantitative and quantitative real-time reverse transcriptase polymerase chain reaction of 96 surgically resected HCC tissues positive for hepatitis B virus surface antigen. UQCRH was frequently overexpressed in HCC tissues (46.8%, based on 2.1-fold cutoff). UQCRH overexpression was observed in HCCs with larger tumor size, poorer differentiation, or vascular invasion. Kaplan–Meier analysis revealed significantly shorter overall (P = 0.005) and recurrence-free survival (P = 0.027) in patients with tumors overexpressing UQCRH. The prognostic impact of UQCRH was significant in subgroups of patients divided according to the α-fetoprotein (AFP) level. The patient subgroup with higher AFP levels (≥20 ng/mL) exhibited significant differences in 5-year overall (18.5% vs. 67.9%) and recurrence-free survival rates (11.1% vs. 46.4%) between groups with and without UQCRH overexpression. In contrast, no marked survival differences were observed between subgroups with lower AFP levels (<20 ng/mL). Multivariate analysis defined UQCRH as an independent poor prognostic factor. Conclusively, our results indicate that UQCRH overexpression is correlated with poor outcomes of HCC patients. Furthermore, in patients grouped as high risk based on elevated AFP, lack of UQCRH overexpression could be a useful indicator for clinical treatment.

AB - Alterations in mitochondrial respiration contribute to the development and progression of cancer via abnormal biogenesis, including generation of reactive oxygen species. Ubiquinol–cytochrome c reductase hinge protein (UQCRH) consists of the cytochrome bc1 complex serving respiration in mitochondria. In the present study, we analyzed UQCRH abnormalities in hepatocellular carcinoma (HCC) and its association with clinical outcomes of patients. UQCRH expression in HCC was determined via semiquantitative and quantitative real-time reverse transcriptase polymerase chain reaction of 96 surgically resected HCC tissues positive for hepatitis B virus surface antigen. UQCRH was frequently overexpressed in HCC tissues (46.8%, based on 2.1-fold cutoff). UQCRH overexpression was observed in HCCs with larger tumor size, poorer differentiation, or vascular invasion. Kaplan–Meier analysis revealed significantly shorter overall (P = 0.005) and recurrence-free survival (P = 0.027) in patients with tumors overexpressing UQCRH. The prognostic impact of UQCRH was significant in subgroups of patients divided according to the α-fetoprotein (AFP) level. The patient subgroup with higher AFP levels (≥20 ng/mL) exhibited significant differences in 5-year overall (18.5% vs. 67.9%) and recurrence-free survival rates (11.1% vs. 46.4%) between groups with and without UQCRH overexpression. In contrast, no marked survival differences were observed between subgroups with lower AFP levels (<20 ng/mL). Multivariate analysis defined UQCRH as an independent poor prognostic factor. Conclusively, our results indicate that UQCRH overexpression is correlated with poor outcomes of HCC patients. Furthermore, in patients grouped as high risk based on elevated AFP, lack of UQCRH overexpression could be a useful indicator for clinical treatment.

KW - AFP

KW - hepatocellular carcinoma

KW - Mitochondria

KW - Prognosis

KW - UQCRH overexpression

UR - http://www.scopus.com/inward/record.url?scp=85016409274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016409274&partnerID=8YFLogxK

U2 - 10.1002/cam4.1042

DO - 10.1002/cam4.1042

M3 - Article

C2 - 28332314

AN - SCOPUS:85016409274

VL - 6

SP - 749

EP - 760

JO - Cancer Medicine

JF - Cancer Medicine

SN - 2045-7634

IS - 4

ER -